Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Narod

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Nature Reviews. Clinical Oncology|November 18, 2015
Breast cancer: The importance of overdiagnosis in breast-cancer screeningSteven Narod
Journal of the National Cancer Institute|March 18, 2014
ResponseSteven Narod
JAMA Oncology|January 11, 2019
Association Between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene MSH6Steven Narod
Lancet (London, England)|May 4, 2002
What options for treatment of hereditary breast cancer?Steven Narod
JAMA Oncology|October 2, 2015
Genetic Testing for BRCA Mutations Today and Tomorrow-About the ABOUT StudySteven Narod
Hereditary Cancer in Clinical Practice|March 18, 2010
The prevention of hereditary breast and ovarian cancer: a personal viewSteven Narod
Nature Reviews. Clinical Oncology|January 21, 2016
Can advanced-stage ovarian cancer be cured?Steven Narod
Women'S Health (London, England)|March 2, 2012
BRCA1 haploinsufficiency: consequences for breast cancerLeonardo Salmena, Steven Narod
Gynecologic Oncology|December 27, 2016
Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?Steven Narod, Victoria Sopik
Journal of the National Cancer Institute|October 16, 2003
Re: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's diseaseSteven Narod, Jan Lubinski
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Nature Reviews. Clinical Oncology|November 18, 2015
Breast cancer: The importance of overdiagnosis in breast-cancer screeningSteven Narod
Journal of the National Cancer Institute|March 18, 2014
ResponseSteven Narod
JAMA Oncology|January 11, 2019
Association Between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene MSH6Steven Narod
Lancet (London, England)|May 4, 2002
What options for treatment of hereditary breast cancer?Steven Narod
JAMA Oncology|October 2, 2015
Genetic Testing for BRCA Mutations Today and Tomorrow-About the ABOUT StudySteven Narod
Hereditary Cancer in Clinical Practice|March 18, 2010
The prevention of hereditary breast and ovarian cancer: a personal viewSteven Narod
Nature Reviews. Clinical Oncology|January 21, 2016
Can advanced-stage ovarian cancer be cured?Steven Narod
Women'S Health (London, England)|March 2, 2012
BRCA1 haploinsufficiency: consequences for breast cancerLeonardo Salmena, Steven Narod
Gynecologic Oncology|December 27, 2016
Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?Steven Narod, Victoria Sopik
Journal of the National Cancer Institute|October 16, 2003
Re: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's diseaseSteven Narod, Jan Lubinski
Pageof 10